维普期刊资源整合服务平台（V6.5）

36篇 您的检索式：作者名="Brakora"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Inhibitian of ABOB1 (MDR1) and ABCD4 ( MDR3 ) expression by small interfering RNA and reversal of paclitexel resistance in human ovarian cancer cells 显示文摘	Duan Z Brakora KA Seiden MV	2004	Mol Cancer Ther2004，3，7：	1
2	Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer显示文摘	Brakora KA Lee H Yusuf R	2004	Gynecol Oncol2004，93，2：	1
3	Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer 显示文摘	Brakora KA Lee H Yusuf R	2004	Gynecol Oncol2004，93，2：	1
4	Utility of osteopontin as a biomarker in Recurrent epithelial ovarian cancer 显示文摘	Brakora KA Lee H Yusuf R	2004	Gynecol Oncol2004，93，：	1
5	Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer显示文摘	Brakora KA Lee H Yusuf R	2004	Gynecol Oncol2004，93，：	1
6	Utility of osteopontin as a biomark-er in recurrent epithelial ovarian cancer显示文摘	Brakora KA Lee H Yusuf R		0，，：	1
7	Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer显示文摘	Brakora KA Lee H Yusuf R	2004	Gynecol Oncol2004，93，2：	1
8	Inhibition of ABCBl (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells显示文摘	Duan Z Brakora KA Seiden MV	2004	Mol Cancer Ther2004，3，7：	1
9	Inhibition of ABCB1 (MDR1) and ABCB4(MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells显示文摘	Duan Z Brakora KA Seiden MV	2004	Mol Cancer Ther2004，3，7：	1
10	Inhibition of ABCB1 (MDR1) and ABCB4 (MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells 显示文摘	Duan Z Brakora KA Seiden MV	2004	Mol Cancer Ther2004，3，7：	1
11	Utility of osteopotin as a biomarker in recurrent epithelial ovarian cancer显示文摘	LEE H YUSUF R	2004	Gynecologic Oncology2004，93，：	1
12	Inhibition of ABCB1(MDR1) and ABCB4(MDR3) expression by small interfering RNA and reversal of paclitaxel resistance in human ovarian cancer cells显示文摘	Duan Z Brakora KA Seiden MV	2004	Mol Cancer Ther2004，3，7：	1
13	Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer显示文摘	Brakora K A Lee H Yusuf R	2004	Gynecol Oncol2004，93，2：	1
14	Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer 显示文摘	Brakora KA Lee H Yusuf R	2004	Gynecol Oncol2004，93，2：	1
15	Utility of esteopontin as a biomarker in recurrent epithelial ovarian cancer 显示文摘	Brakora KA Lee H Yusuf R	2004	Gynecol Oncol2004，93，2：	1
16	Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer显示文摘	Brakora KA Lee H Yusuf R	2004	Gynecol Oncol2004，93，2：	1
17	Utility of osteopontin as a bio-marker in recurrent epithelial ovarian cancer显示文摘	BRAKORA KA LEE H YUSUF R	2004	Gynecol Oneol2004，93，2：	1
18	Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer 显示文摘	Brakora KA Lee H Yusuf R	2004	Gyneeol Oncol2004，93，2：	1
19	Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer 显示文摘	Brakora KA Lee H Yusuf R	2004	GynecolOncol2004，93，2：	1
20	Utility of osteopontin as a biomarker in recurrent epithelial ovarian cancer显示文摘	Lee H Yuanf R	2004	Gynecol Oncol2004，93，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示